Literature DB >> 31369798

Developing zebrafish experimental animal models relevant to schizophrenia.

Konstantin A Demin1, Darya A Meshalkina2, Andrey D Volgin3, Oleg V Yakovlev4, Murilo S de Abreu5, Polina A Alekseeva1, Ashton J Friend6, Anton M Lakstygal7, Konstantin Zabegalov8, Tamara G Amstislavskaya9, Tatyana Strekalova10, Wandong Bao11, Allan V Kalueff12.   

Abstract

Schizophrenia is a severely debilitating, lifelong psychiatric disorder affecting approximately 1% of global population. The pathobiology of schizophrenia remains poorly understood, necessitating further translational research in this field. Experimental (animal) models are becoming indispensable for studying schizophrenia-related phenotypes and pro/antipsychotic drugs. Mounting evidence suggests the zebrafish (Danio rerio) as a useful tool to model various phenotypes relevant to schizophrenia. In addition to their complex robust behaviors, zebrafish possess high genetic and physiological homology to humans, and are also sensitive to drugs known to reduce or promote schizophrenia clinically. Here, we summarize findings on zebrafish application to modeling schizophrenia, as well as discuss recent progress and remaining challenges in this field. We also emphasize the need in further development and wider use of zebrafish models for schizophrenia to better understand its pathogenesis and enhance the search for new effective antipsychotics.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Negative symptoms; Positive symptoms; Rodent models; Schizophrenia; Translational research; Zebrafish

Mesh:

Year:  2019        PMID: 31369798     DOI: 10.1016/j.neubiorev.2019.07.017

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  3 in total

1.  The importance of individual variation for the interpretation of behavioural studies: ethanol effects vary with basal activity level in zebrafish larvae.

Authors:  Raissa Davis; Floris Luchtenburg; Michael Richardson; Marcel Schaaf; Christian Tudorache; Hans Slabbekoorn
Journal:  Psychopharmacology (Berl)       Date:  2021-09-11       Impact factor: 4.415

Review 2.  Zebrafish, Medaka and Turquoise Killifish for Understanding Human Neurodegenerative/Neurodevelopmental Disorders.

Authors:  Kazuki Kodera; Hideaki Matsui
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

3.  Towards Modeling Anhedonia and Its Treatment in Zebrafish.

Authors:  Murilo S de Abreu; Fabiano Costa; Ana C V V Giacomini; Konstantin A Demin; Konstantin N Zabegalov; Gleb O Maslov; Yuriy M Kositsyn; Elena V Petersen; Tatiana Strekalova; Denis B Rosemberg; Allan V Kalueff
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.